Peptide therapy that influences growth hormone and metabolic pathways requires careful monitoring, medical supervision and long-term follow-up to ensure safety, effectiveness and sustainable results
This review summarizes the current research findings by which GLP-1RAs treatment of diabetic osteoporosis, postmenopausal osteoporosis and glucocorticoid-induced osteoporosis and describes possible mechanisms, such as GLP-1R/MAPK signaling pathway, GLP-1R/PI3K/AKT signaling pathway and Wnt/-catenin pathway, that are associated with GLP-1RAs and osteoporosis
Ongoing follow-ups & lab monitoring Monitoring as needed for safety and best outcomes
occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration
It preserves lean muscle, supports metabolic rate, promotes satiety, and requires more energy to digest than carbohydrates or fat
Is GLP-1 Plus safe to take with prescription medications